PLSIA (Premier Laser Systems) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PLSIA (Premier Laser Systems)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kvogel who wrote (841)	6/26/1997 6:49:00 PM
From: Jeff Mills	of 1773

Headline: Blue Stone Capital Reiterates STRONG BUY rating on Premier Laser Systems ====================================================================== NEW YORK--(BUSINESS WIRE)--June 26, 1997--Senior Analyst, Scott Baily at BlueStone Capital reiterates his investment rating on Premier Laser Systems, Inc. (NASDAQ:PLSIA) of a STRONG BUY recommendation. Our new 12-month price target is $17-$20, up from our original target of $12-$15. -- Due to anticipated demand for the Centauri hard-tissue lasers, we have increased our fiscal 1998 (March) revenue and EPS estimates to $30 million and $0.14, up from our previous estimates of $20 million and break-even EPS. We have also increased our fiscal 1999 estimates to revenues of $60 million and EPS of $0.42. -- This week PLSIA announced that its Centauri Er:YAG laser system met the electrical performance standards of the International Electrotechnical Commission (IEC) for European countries. The IEC approval opens the European markets to PLSIA's Centauri laser, which will be introduced in Europe this fall. -- PLSIA plans to expand its training courses for the Centauri hard-tissue laser both in the U.S. and internationally to accommodate the anticipated demand for the laser. -- During the last seven weeks PLSIA has generated in excess of $23.5 million in proceeds from the voluntary exercise of warrants of its publicly traded Class A (PLSIW) and Class B (PLSIZ) Warrants. BlueStone Capital Partners, L.P. is a full service investment banking and brokerage firm that delivers financial services to emerging growth and medium size companies worldwide. BlueStone Capital assists clients in maximizing their growth by providing sophisticated investment strategies that are designed to achieve clients' strategic, operating and financial goals. CONTACT: BlueStone Capital Partners, L.P. Scott Baily, 212/850-0558 KEYWORD: NEW YORK INDUSTRY KEYWORD: BANKING MEDICINE

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next